Skip to main content
. Author manuscript; available in PMC: 2011 Dec 1.
Published in final edited form as: Transfusion. 2010 Dec;50(12):2738–2744. doi: 10.1111/j.1537-2995.2010.02748.x

Figure 2.

Figure 2

The annual incidence of TACO before (1993-99) and after (2001-07) the introduction of universal leukoreduction (ULR) in the year 2000 is shown. The incidence rate was 5 or fewer cases per 100,000 components transfused in six of the seven years post-introduction of ULR, compared with only two of the seven years pre-introduction of ULR.